Outcomes from Explantation of Laparoscopic Adjustable Gastric Band: Experience from a Canadian Bariatric Center of Excellence

التفاصيل البيبلوغرافية
العنوان: Outcomes from Explantation of Laparoscopic Adjustable Gastric Band: Experience from a Canadian Bariatric Center of Excellence
المؤلفون: Shannon, Stogryn, Garrett G R J, Johnson, Allan, Okrainec, Timothy, Jackson, Ashley, Vergis
المصدر: Obesity surgery. 31(11)
سنة النشر: 2021
مصطلحات موضوعية: Reoperation, Canada, Postoperative Complications, Treatment Outcome, Gastroplasty, Gastric Bypass, Bariatric Surgery, Humans, Laparoscopy, Obesity, Morbid, Retrospective Studies
الوصف: Laparoscopic adjustable gastric banding (LAGB) has declined in popularity due to poor weight loss and high revision rates. The study aim was to evaluate complication rates following LAGB removals, including conversions to other bariatric procedures.This was a retrospective cohort study of patients who underwent LAGB removal, identified from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database from the Toronto Western Hospital site. Patients were filtered using principal procedure and concurrent procedural terminology (CPT) codes. Patients converted to other bariatric procedures were also included. Outcomes were evaluated for 30-day morbidity, mortality, readmissions, and costs.From 2012 to 2018, 93 patients met inclusion. 96.77% had elective surgery, and 3.23% were emergent. Thirty-day postoperative complication rate was 11.83%, with 4.30% readmissions and no deaths. Surgical site infections accounted for 81.82% of complications (54.55% superficial, 27.27% deep). Thirty-day complication rate for LAGB removal alone was 17.50% and 33.33% following emergent explantation. 56.99% LAGBs were converted to other bariatric procedures: 48.39% laparoscopic Roux-en-Y gastric bypass (LRYGB) and 8.6% sleeve gastrectomy (LSG). Conversion to LSG had a significantly higher 30-day complication rate (all Clavien-Dindo class I-II) compared to conversion to LRYGB (37.50% versus 2.22%, p 0.009). Direct costs of LAGB explantation to the healthcare system were $665,443, amounting to $7,155 per patient.Thirty-day complication rates for LAGB explantation and conversion to other bariatric procedures are significant and may be higher than previously reported for LAGB removal alone. Conversion to LSG may have the highest complication rate, amounting to significant costs.
تدمد: 1708-0428
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::8c2a11b1250fb96fb686a0227733df43
https://pubmed.ncbi.nlm.nih.gov/34427867
رقم الانضمام: edsair.pmid..........8c2a11b1250fb96fb686a0227733df43
قاعدة البيانات: OpenAIRE